Bank of Montreal
LRMR icon

Bank of Montreal’s Larimar Therapeutics LRMR Stock Holding History

Bank of Montreal’s Portfolio LRMR Stock Details LRMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-4
Closed – – 4875
2019
Q2 		$0 Buy
+4
New +$107 ﹤0.01% 4993
2019
Q1 		– Sell
-36
Closed -$1.84K – 4554
2018
Q4 		$2K Buy
36
+18
+100% +$1.78K ﹤0.01% 4388
2018
Q3 		$2K Buy
18
+4
+29% +$486 ﹤0.01% 4368
2018
Q2 		$2K Buy
+14
New +$1.19K ﹤0.01% 4369
2016
Q4 		– Sell
-61
Closed -$2K – 4133
2016
Q3 		$2K Buy
+61
New +$2.77K ﹤0.01% 3856

Other funds holding LRMR

AVA
Atlas Venture Advisors Boston, Massachusetts $143M AUM 25.68% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
MP
Mangrove Partners Greenwich, Connecticut $1.24B AUM 41.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Bank of Montreal's LRMR Position: Q3 2019 in Review

Bank of Montreal sold out of Larimar Therapeutics (LRMR) in Q3 2019, closing a stake of 4 shares.

Bank of Montreal first reported a position in LRMR in Q3 2016 and held it in 5 quarters. The position peaked at $2K in Q4 2018. 51 funds tracked by Wall St. Rank hold LRMR as of Q3 2019.

  • Bank of Montreal reported no remaining Larimar Therapeutics position as of Q3 2019 after selling out during the quarter.
  • Bank of Montreal sold 4 Larimar Therapeutics shares in Q3 2019.
  • Bank of Montreal first reported a position in Larimar Therapeutics in Q3 2016 and held it in 5 quarters.
  • Bank of Montreal's Larimar Therapeutics position peaked at $2K in Q4 2018.
  • 51 funds tracked by Wall St. Rank held Larimar Therapeutics as of Q3 2019.

Based on Bank of Montreal's 13F filing for Q3 2019, filed 8 Nov 2019.